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Engineering and kMedicine, Boston University, Boston, MassachusettsABSTRACT While significant advances have been made toward revealing the molecular mechanisms that influence breast
cancer progression, much less is known about the associated cellular mechanical properties. To this end, we use particle-
tracking microrheology to investigate the interplay among intracellular mechanics, three-dimensional matrix stiffness, and trans-
forming potential in a mammary epithelial cell (MEC) cancer progression series. We use a well-characterized model system
where human-derived MCF10A MECs overexpress either ErbB2, 14-3-3z, or both ErbB2 and 14-3-3z, with empty vector as
a control. Our results show that MECs possessing ErbB2 transforming potential stiffen in response to elevated matrix stiffness,
whereas non-transformedMECs or those overexpressing only 14-3-3z do no exhibit this response.We further observe that over-
expression of ErbB2 alone is associated with the highest degree of intracellular sensitivity to matrix stiffness, and that the effect
of transforming potential on intracellular stiffness is matrix-stiffness-dependent. Moreover, our intracellular stiffness measure-
ments parallel cell migration behavior that has been previously reported for these MEC sublines. Given the current knowledge
base of breast cancer mechanobiology, these findings suggest that there may be a positive relationship among intracellular stiff-
ness sensitivity, cell motility, and perturbed mechanotransduction in breast cancer.INTRODUCTIONGiven that the vast majority of breast cancer-related deaths
result from metastasis, understanding the interplay between
the cellular microenvironment and breast cancer metastatic
potential is critically important to the development of
effective treatments and therapies for this disease. While
significant progress has been achieved toward elucidating
the molecular mechanisms that underlie breast cancer
progression (1,2), quantitative characterization of the asso-
ciated cellular mechanical properties remains largely
incomplete. Breast tumors are more rigid (stiffer) than
normal breast tissue (3), and cancer cell motility, a key
aspect of metastasis, is in part governed by the stiffness of
the extracellular matrix (ECM) (4). However, the system-
wide relationships among ECM mechanical properties,
transforming potential, and the intracellular mechanical
state of breast cancer cells is even less well understood,
particularly within the context of physiologically relevant,
three-dimensional matrix environments.
A number of breast cancer biomarkers have been identi-
fied and linked to specific stages of the disease, notably
including the ErbB2 (HER2/neu) and 14-3-3z proteins,
both of whose overexpression has been correlated with
poor prognoses (5,6). ErbB2 is a transmembrane receptor
tyrosine kinase of the epidermal growth factor receptor
family of proteins; it is involved in several signaling path-
ways that modulate cell growth, differentiation, and apo-Submitted April 20, 2010, and accepted for publication July 23, 2010.
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0006-3495/10/10/2048/10 $2.00ptosis, among other critical processes (7). Cells cultures
that overexpress ErbB2 have been shown to exhibit hyper-
plasia (8), and they have also shown a capacity to overcome
apoptotic signals (9). Strikingly, the ErbB2 protein is over-
expressed in ~25% of all invasive and metastatic breast
cancers (6); its role in promoting metastasis of breast and
other forms of cancer has rendered ErbB2 one of the most
studied molecules in the field of cancer and a critical target
for drug development (10). The 14-3-3z protein belongs to
the larger family of seven 14-3-3 regulatory proteins that
are widely expressed and involved in a variety of cellular
homeostatic processes, including a general cell survival/
anti-apoptotic mechanism (11). Recent mammary epithelial
cell (MEC) in vitro studies have shown that 14-3-3z con-
fers significant resistance to anoikis (12), a specific type
of apoptosis that occurs when epithelial cells detach from
extracellular ligands, thus promoting luminal filling and
driving MECs toward transformation (13). Overexpression
of 14-3-3z has additionally been shown to induce notable
morphological irregularities that are characteristic of pro-
gression toward an invasive phenotype (12,14). Further-
more, analyses of patient biopsies indicate that >40% of
advanced metastatic breast cancers overexpress the 14-3-
3z protein (5).
Despite their capacities to confer oncogenic properties
to non-transformed cells, overexpression of either ErbB2
or 14-3-3z alone is not sufficient to drive complete transfor-
mation in vitro (8,12). However, recent investigations
have shown that their cooperative effect does promote
progression from non-invasive carcinoma to invasive anddoi: 10.1016/j.bpj.2010.07.051
Transforming Potential and Matrix Stiffness Govern Cell Stiffness 2049metastatic breast cancer (14). Given the identified correla-
tions between breast cancer biomarkers and metastatic
progression and our current knowledge of cell-matrix inter-
actions with respect to the cellular mechanical environment,
the following fundamental questions remain unanswered for
individual MECs in three-dimensional environments:
1. Does the intracellular mechanical state adapt to matrix
stiffness?
2. Is this adaptability related to transforming potential?
And:
3. Is there a relationship between intracellular stiffness and
transforming potential given a determined matrix envi-
ronment?
In this study, we quantitatively investigate these questions
by employing particle-tracking microrheology (PTMR)
to examine the effect of matrix stiffness on the intracellular
stiffness of individual MECs that are embedded within
three-dimensional matrices of varied elastic moduli. PTMR
is a passive technique that avoids sample size and accessi-
bility limitations that are presented by alternative rheolog-
ical techniques (15), and it has been utilized extensively to
probe the mechanical behavior of numerous biological
organisms and materials (16,17). PTMR yields the time-
dependent viscoelastic behavior of a material, as extracted
from the thermally driven motions of small probes (tracer
beads) embedded within the material (15,18). PTMR proto-
cols have been established (19,20) and indeed have been
used to link the cytoplasmic mechanical environment of
living cells to the surrounding matrix mechanics (21).
Here we use PTMR to examine human-derived MECs
of varied transforming potential with respect to matrices
formulated from Type I collagen, which is the primary struc-
tural component of the mammary stroma. Additionally, we
examine the morphological differences exhibited among
these MECs within three-dimensional matrices. In total,
our studies provide novel insights into breast cancer mecha-
nobiology by demonstrating that transforming potential
couples with matrix stiffness to govern the intracellular
mechanical state of MECs.MATERIALS AND METHODS
Cell culture
PTMR experiments were performed on stable sublines that were estab-
lished as described previously (14) from the non-cancerous, human-derived
MCF10A MEC line (provided by Dr. Robert Pauley of the Karmonos
Cancer Institute, Detroit, MI). Cell lines were maintained in two-dimen-
sional monolayer culture in DMEM/F12 growth media (22) within a humid-
ified incubator at 37C, 5% CO2 until the time of experimentation.Collagen matrix preparation and characterization
Matrices were formulated from high concentration Type I collagen (BD
Biosciences, San Jose, CA), which was diluted to three concentrationsof 2, 3, and 4 mg/mL. Equal parts collagen and neutralizing solution
(100 mM HEPES in 2 PBS at pH 7.3) were mixed with a balance of
2  105 cells suspended in growth media to achieve the final concentration
(23). Each matrix solution (1 mL) was then deposited across the surface of
a 35-mm glass-bottom dish (MatTek, Ashland, MA). Matrix solutions were
allowed to gel for 2 h at 37C, 5% CO2, upon which 2 mL of growth media
was deposited atop the three-dimensional matrices to provide cells with
adequate nutrients during a subsequent 12 h incubation.
The matrix stiffness was quantified in terms of the bulk elastic modulus
of the collagen gel (G0c). Measurements of G0c were performed on acellular
collagen matrices after they were permitted to gel for 2 h at 37C, 5% CO2.
Four 1-mL samples of each gel were measured with a Physica MCR 300
rheometer (Anton Paar, Ashland, VA) operating in cone-and-plate mode
and stressed at 0.1 mN$m oscillatory torque over a frequency (u) range
of 0.1–10 Hz. Measurements of elastic modulus for each gel concentra-
tion were averaged and then fit to a power-law equation of the form
G0c ¼ aub þ d. At u ¼ 10 Hz, we report G0c as 104, 271, and 391 Pa
for collagen gels of concentration 2, 3, and 4 mg/mL, respectively. Thus,
we modulate matrix stiffness by varying collagen concentration, which
additionally has a negative correlation with matrix pore size and a positive
correlation with ligand density (21). Numerous studies have shown that
modulating concentration has a much greater affect on matrix mechanics-
mediated cell responses than it does on ligand-mediated cell-matrix inter-
actions (4,21,24,25). Thus, we examine our results with respect to changes
in matrix stiffness (26).
Particle delivery and particle-tracking
Cell lines were cultured to confluency in a 10-cm dish and then embedded
with 1.0-mm carboxylated, fluorescent polystyrene tracer beads (Molecular
Probes, Eugene, OR) using a ballistic particle delivery system (BioRad
Laboratories, Hercules, CA) (27). Next, cells were detached and resus-
pended at a concentration of 2  105 cells/mL in growth media. Suspended
cells were mixed with Type I collagen (see above) and incubated for 12 h
(post gelation) at 37C, 5% CO2.
After incubation, xy-plane Brownian motions of individual tracer beads
were imaged within cells in each three-dimensional matrix at 63 magni-
fication for a period of 10 s at a frame rate of 10 Hz using an SP2 AOBS
confocal microscope (Leica Microsystems, Bannockburn, IL). A total of
8–20 tracer beads were imaged in each culture. Only cells that were non-
dividing and wholly suspended within the three-dimensional matrices
(not attached to other cells or the glass-bottom surface) were selected for
imaging. The microscope objective was maintained at 37C with an objec-
tive heater (Bioptechs, Butler, PA). Imaris image analysis software (Bit-
plane, St. Paul, MN) was then utilized to create particle trajectories in the
x,y plane for each tracer bead. For each cell line, the experiment was per-
formed at least three times, yielding an average particle count of N ¼ 40
and an average cell count of M ¼ 29 per collagen matrix. Tracer beads
used in the analyses were locatedR5 mm away from the nearest adjacent
bead to avoid effects due to interparticle forces.
Intracellular rheology
Upon tracking the Brownian motions of individual tracer beads,
we computed their ensemble-averaged, time-dependent mean-squared
displacement (MSD),
D
Dr2ðtÞxy
E
¼ ½xðt þ tÞ  xðtÞ2þ ½yðt þ tÞ  yðtÞ2;
(1)
where hDr2ðtÞxyi is the two-dimensional MSD, t is the elapsed time, and
t is the time lag. Because the ensemble-averaged one-dimensional
MSD hDx2ðtÞi was found to be approximately equal to hDy2ðtÞi (data not
shown), the total three-dimensional MSD hDr2ðtÞi was assumed to be
isotropic and hDr2ðtÞi ¼ hDx2ðtÞi þ hDy2ðtÞi þ hDz2ðtÞi ¼ 3
2
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and fit to a three-term power law of the form hDr2ðtÞi ¼ b1ta1þ
b2t
a2 þ b3ta3 (average R2 of 0.97) using a built-in MATLAB (The Math-
Works, Natick, MA) least-squares algorithm to smooth out trajectory noise.
For cells and other complex materials that exhibit both elastic and
viscous behavior, the MSD at any time locally follows a power-law rela-
tionship, hDr2ðtÞi  ta, where a is the diffusive exponent (18). For a
passive material, the diffusive exponent can range anywhere from a ¼ 0
for a purely elastic solid to a ¼ 1 (simple diffusion) for a purely viscous
liquid. Between these two viscoelastic extremes, embedded particle
motion is described as subdiffusive (0 < a < 1) and reflects the relative
contribution of the elastic and viscous components to the mechanical state
of a material. However, because living cells are active materials, a reflects
not only thermal energy (kBT), but also potential modes of active transport,
which cannot be decoupled from thermal energy by particle-tracking
measurements (28,29). For such cases, particles may exhibit superdiffusive
motion (a > 1), and furthermore, an a < 1 is not a direct, absolute reflec-
tion of intracellular viscoelasticity. It has been shown previously that the
time-dependent creep compliance of a passive material can be extracted
directly from the MSD (30). For the case of living, active cells, the intra-
cellular mechanical state has been described in terms of an effective creep
compliance (31),
JeðtÞ ¼ pa
kBT

Dr2ðtÞ; (2)
where a is the bead radius. Using Je, we describe the intracellular mechan-
ical state in terms of an apparent elastic modulus (G0p) with the relation-
ship (21)
G0p ¼

Je

t¼ 1s
1
: (3)
Because G0p is defined at t ¼ 1 s and not computed from a plateau compli-
ance, we utilize it to describe relative intracellular stiffness as opposed to an
absolute measure of intracellular elasticity.Live cell morphology characterization
Adherent cells in two-dimensional monolayer culture were stained with
Cell Tracker Green CMFDA (Molecular Probes, Eugene, OR) and resus-
pended at a concentration of 5  105 cells/mL within three-dimensional
collagen matrices. After gelation and addition of media as described
above, matrices were further incubated for 12 h at 37C, 5% CO2 before
imaging. Only individual cells that were wholly suspended within the
three-dimensional matrices were selected for imaging. Three samples of
each collagen gel were imaged, with 15 cells imaged at random per condi-
tion of cell line and matrix stiffness. Confocal images of the cells were
obtained using the LSM 5 Live (Carl Zeiss, Thornwood, NY). We quantify
the morphology of the cells in terms of the sphericity (J), which describes
the shape of a three-dimensional object relative to that of a sphere. Sphe-
ricity is defined as the ratio of the surface area of a sphere (with the same
volume as the given object) to the surface area of the given object; sphe-
ricity reaches a maximum value of 1 for a perfect sphere. Sphericity was
computed using Imaris (Bitplane) iso-surface renderings of the recon-
structed confocal images.RESULTS
ErbB2 transforming potential promotes
intracellular stiffening in response to increased
matrix stiffness
To explore the relationship between breast cancer trans-
forming potential and the intracellular mechanical environ-Biophysical Journal 99(7) 2048–2057ment, we examined a well-characterized cancer progression
series established from the non-transformed, human-derived
MCF10A cell line. We analyzed four sublines, whose extent
of transforming potential is determined by their growth
traits and morphological features when permitted to form
acinar structures in three-dimensional culture (14). The
sublines consisted of
1. 10A.vec—a non-transformed control cell line.
2. 10A.ErbB2—a hyperplastic, partially transformed cell
line that overexpressed ErbB2.
3. 10A.14-3-3z—a depolarized and morphologically
abnormal, partially transformed cell line that overex-
pressed 14-3-3z.
And:
4. 10A.ErbB2.z—an invasive, fully transformed cell line
that overexpressed both ErbB2 and 14-3-3z.
PTMR analyses showed that adjusting the matrix stiffness
G0c had a notable effect on the Brownian dynamics of tracer
beads embedded within MECs that exhibited the ErbB2
transformation profile (10A.ErbB2 and 10A.ErbB2.z), rela-
tive to control cells (10A.vec) and 10A.14-3-3z cells. This is
illustrated for the 10A.ErbB2.z cell line (Fig. 1 A), in which
the overall MSD magnitudes decrease as matrix stiff-
ness increases; compare to the MSD magnitudes for the
10A.vec line (Fig. 1 B), which reveal no clear association
with matrix stiffness. By extension, increasing the matrix
stiffness accordingly yields an increase in intracellular
apparent stiffness G0p for MECs that possess the ErbB2
transformation profile (Fig. 2, B and D), yet increasing the
matrix stiffness does not invoke a significant intracellular
stiffening response in non-transformed MECs or those ex-
hibiting the 14-3-3z transformation profile alone (Fig. 2, A
and C). Therefore, our results suggest that overexpression
of ErbB2, either alone or in cooperation with 14-3-3z,
confers individual MECs with the capacity to adapt their
intracellular mechanical state to ECM mechanical cues.ErbB2 is associated with increased intracellular
mechanical sensitivity
Further comparative examination of our PTMR data shows
that overexpression of ErbB2 alone is associated with the
highest degree of intracellular mechanical sensitivity to
matrix stiffness. This sensitivity is mitigated for cells that
do not overexpress ErbB2 (10A.14-3-3z), but partially
restored for cells that co-overexpress both ErbB2 and 14-
3-3z. This is illustrated in Fig. 3 (wide bars), which shows
the percent increase in intracellular apparent stiffness as
the matrix stiffness is increased from 104 to 391 Pa for the
sublines that exhibit transforming potential. In fact, previous
analyses of these sublines showed a strikingly similar rela-
tionship between ErbB2 status and cell motility (quantified
by trans-well migration): 10A.ErbB2 cells exhibited the
AB
FIGURE 1 Matrix stiffness influences Brownian dynamics of tracer
beads embedded within MECs that possess ErbB2 transforming potential.
MSD of 1 mm tracer beads embedded within 10A.ErbB2.z (A) and
10A.vec (B) cells that reside within three-dimensional Type I collagen
matrices of stiffness 104 (B), 271 (- - -), and 391 (—) Pa. Error bars omitted
for figure clarity.
FIGURE 3 ErbB2 sensitizes the intracellular mechanical state to matrix
stiffness. Wide bars (red) represent the % increase in intracellular apparent
stiffness G0p as matrix stiffness G0c is increased from 104 to 391 Pa.
P-values (*, p % 0.05; y, p % 0.10) determined from t-tests for unpaired
samples; p-values reflect the significance of the highest intracellular stiff-
ness relative to the lowest intracellular stiffness of the given cell line as
reported in Fig. 2. Thin bars (14) represent the number of migrated cells
counted per field of view, after a 6 h trans-well cell migration assay. Initial
cell seeding count was maintained at 1  105 cells for all cell lines (migra-
tion data retrieved from (14)). Error bars represent mean 5 SE.
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cells and then by 10A.14-3-3z cells (Fig. 3, narrow bars)
(14). Although the experimental system employed previ-
ously to examine motility was different than that utilizedA B Cto investigate intracellular stiffness for this study, the two
results suggest that there may be a link between motility
and the intracellular mechanical state of individual MECs
that possess transforming potential.Matrix stiffness couples with transforming
potential to determine intracellular stiffness
Next,we compare the intracellularmechanical state ofMECs
with respect to transforming potential for a givenmatrix envi-
ronment. PTMR results indicate that within the softest matrix
(Fig. 4 A), intracellular apparent stiffness is reduced for
partially transformed 10A.14-3-3z cells and fully trans-
formed 10A.ErbB2.z cells (relative to 10A.vec cells), while
in a matrix of moderate stiffness (Fig. 4 B), none of the cell
sublines show a significant difference in intracellular
apparent stiffness. In the stiffest matrix (Fig. 4 C), however,
ErbB2 status is the dominant factor that influences G0p.
In thismatrix environment, cells overexpressingErbB2 alone
exhibit the highest intracellular stiffness, followed by cells
co-overexpressing both ErbB2 and 14-3-3z. A closer analysis
of this data reveals another important observation: increasing
the matrix stiffness progressively shifts the difference inD
FIGURE 2 MECs that possess ErbB2 transform-
ing potential stiffen in response to elevated matrix
stiffness. Intracellular apparent stiffness G0p
increases as matrix stiffness G0c increases for cell
lines that overexpress ErbB2 (B and D) but does
not significantly increase for 10A.vec (A) or
10A.14-3-3z cells (C). Error bars represent
mean5 SE. P-values (*, p % 0.05; y, p % 0.10)
determined from t-tests for unpaired samples;
p-values are with respect to the lowest intracellular
stiffness of the given cell line.
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FIGURE 4 Matrix stiffness affects the relationship between transforming potential and intracellular stiffness. Intracellular apparent stiffness G0p of
MCF10A sublines for matrices of stiffness 104 (A), 271 (B), and 391 (C) Pa. Error bars represent mean5 SE. (D) Difference between G0p of 10A.vec cells
andG0p of 10A.ErbB2.z cells as a function of matrix stiffnessG0c.. P-values (*, p% 0.05; y, p% 0.10) determined from t-tests for unpaired samples; p-values
are with respect to intracellular stiffness of 10A.vec cells.
2052 Baker et al.intracellular apparent stiffness between non-transformed
cells (10A.vec) and fully invasive cells (10A.ErbB2.z)
(Fig. 4 D). In the softest matrix (104 Pa), non-transformed
MECs are notably stiffer than fully invasive ones. However,
as the matrix stiffness increases to 271 Pa, this differential
reverses, becomes only slight in magnitude, and becomes
statistically insignificant, while in the stiffest matrix (391 Pa),
the reversed differential becomes more pronounced. To
summarize, Table 1 provides a compilation of the relevant
parameters associated with the sublines examined here.
Overall, these results show that the interplay between trans-
forming potential and the intracellular mechanical state of
MECs is not a simple, singular association. Rather, it is
a matrix stiffness-dependent phenomenon that may have an
important bearing on how we characterize the mechanical
state of healthy and cancerous breast tissues.Single MEC morphology in three-dimensional
matrices is dictated by protein expression
Previous observation of monolayer cultures have shown that
the two-dimensional morphology of the present MCF10A
sublines is correlated with expression of biomarkers: non-
transformed (10A.vec) and hyperproliferative (10A.ErbB2)TABLE 1 Summary of relevant parameters associated with MCF10
Subline Cancer progression Sphericity Motility (%) (1
10A.vec Non-transformed 0.98 0.26
10A.ErbB2 Partially transformed 0.97** 1.00
10A.14-3-3z Partially transformed 0.90*** 0.44
10A.ErbB2.z Fully transformed 0.79*** 0.82
Sphericity is that of single cells embedded wholly within 3D Type I collagen m
mined from t-tests for unpaired samples; p-values are with respect to the sphe
10A.ErbB2 cells counted per field of view, following a 6 h trans well cell migratio
in intracellular apparent stiffness as matrix stiffness is increased from 104 to 391
samples; p-values compare the intracellular stiffness of cells within a matrix of
ential, notated as positive (þ) or negative (), is the difference in intracellular
Biophysical Journal 99(7) 2048–2057sublines exhibit a cobblestone-like morphology, whereas the
depolarized and fully invasive cell lines (those overexpress-
ing 14-3-3z) exhibit an elongated, spindle-like morphology
on flat substrates (14). Similarly, three-dimensional acinar
structures for 10A.vec and 10A.ErbB2 cells exhibit a defined
boundary (9,14), whereas those of 10A.14-3-3z and
10A.ErbB2.z are characterized by an abnormal morphology
with a less-defined boundary (12,14). Our observations of
individual MCF10A cell morphology in three-dimensional
matrices is consistent with prior findings for two-dimen-
sional cultures and three-dimensional aggregate struc-
tures; individual 10A.vec and 10A.ErbB2 cells exhibit a
round, spherical morphology in three-dimensional collagen
matrices, whereas individual 10A.14-3-3z and 10A.ErbB2.z
cells exhibit an elongated, irregular shape (Fig. 5, A–D).
This morphology is quantified in terms of sphericity (J),
which we find highest for 10A.vec cells (nearly perfectly
spherical) and lowest for 10A.ErbB2.z cells (Fig. 5 E).
Imaging did not show a consistent sphericity dependence
on matrix stiffness, which may seem contrary to previously
published morphological studies of MECs within three-
dimensional matrices (3,32,33); however, these prior studies
examined morphology of cell aggregates, and cells were
observed over much longer periods of exposure toA cancer progression series
4) Stiffness sensitivity (% increase) Stiffness differential (þ/)
— —
221* —
33 —
93y þ For high G0c
 For low G0c
atrices of stiffness 391 Pa. P-values (***, p% 0.001; **, p% 0.01) deter-
ricity of 10A.vec cells. Motility is normalized by the number of migrated
n assay (data retrieved (14)). Stiffness sensitivity is quantified as % increase
Pa. P-values (*, p% 0.05; y, p% 0.10) determined from t-tests for unpaired
stiffness 391 Pa to cells within a matrix of stiffness 104 Pa. Stiffness differ-
apparent stiffness between 10A.vec cells and that of 10A.ErbB2.z cells.
A B
C
D
E
FIGURE 5 14-3-3z alters MCF10A single-cell
morphology in three-dimensional matrices. Images
of live, individual 10A.vec (A), 10A.ErbB2 (B),
10A.14-3-3z (C), and 10A.ErbB2.z (D) cells
embedded wholly within three-dimensional Type
I collagen matrices of stiffness 391 Pa. Scale
bar ¼ 20 mm. (E) Sphericity J of MCF10A
sublines embedded wholly within three-dimen-
sional Type I collagen matrices of stiffness 391 Pa.
Error bars represent mean 5 SE. P-values (***,
p% 0.001; **, p% 0.01) determined from t-tests
for unpaired samples; p-values are with respect to
the sphericity of 10A.vec cells.
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dependence on matrix stiffness may in part reflect cellular
matrix metalloproteinase (MMP) secretion, which is similar
among the four sublines examined here (14). MMP secre-
tion may counter the effect of ECM structural barriers that
would otherwise be imposed on the cell bodies by increased
collagen content, thereby allowing the cells to roughly
maintain their shape in the presence of density-induced
matrix stiffness. Given that the cells are permitted to migrate
freely through the collagen matrix in this experimental
design, MMP secretion coupled with the amoeboid mode
of motility may further enable the cells to maintain their
sphericity, even as matrix pore size decreases (34,35).DISCUSSION
The rheological behavior of a single cell is governed by the
constituency of its cytoplasm (36), the forces exerted on it
by the surrounding ECM (37), and the integrins that connect
its cytoskeleton to the ECM (38). Increasingly, cancer cells
are becoming the focus of studies that explore the effect of
the extracellular environment on cellular homeostasis (3,39)
and cellular viscoelasticity (21,40). While significant prog-
ress has been achieved in discovering some of the molecular
mechanisms and signaling pathways that underlie breast
and other cancers (7,11), much less is known about the asso-
ciated cellular mechanical properties. It is has long been
established that cancerous breast tissue exhibits elevated
stiffness compared to healthy mammary tissues (3); how-ever, the relationship between the external cellular mechan-
ical environment and the intracellular mechanical state of
breast cancer is not understood. The mechanical interplay
between external and internal cellular compartments is
further confounded by the stage of breast cancer progression
and may also have a significant bearing on breast cancer
cell migration. In order to investigate the interplay among
three-dimensional matrix mechanics, the internal cellular
mechanical state, and transforming potential in breast
cancer, we have utilized PTMR to gauge the relative intra-
cellular stiffness of MECs within three-dimensional Type I
collagen matrices. By examining a breast cancer progres-
sion series of sublines that derive from a single MEC parent
line, we are able to offer direct comparisons among cells of
varying transforming potential.
Clarifying breast cancer progression at a fundamental
level (the interaction of a cell with its surrounding microen-
vironment) will improve the basis for understanding and
addressing cancer at the systems level, as evidenced by
the recent, growing body of single cancer cell investigations
(3,21,39,41). The in vivo extracellular microenvironment
consists of several components, including but not limited
to cells, ECM proteins, vessels, etc., all of which possess
distinct mechanical properties and individual roles in tissue
homeostasis; the relative balance and significance of these
components depend upon the extent of cancer progression.
In this study, we have focused on probing the intracellular
mechanical state of MECs that have the capacity to freely
navigate the ECM, which is physiologically relevant toBiophysical Journal 99(7) 2048–2057
2054 Baker et al.individual MECs that have invaded their local ductal base-
ment membrane and may exhibit motility within the
ECM. We examined single cells that are wholly engaged
with the matrix (but unattached to other cells) in order to
experimentally control the degree and type of cell surface
attachment. Accordingly, the MECs examined here form
cell-matrix attachments via b1 integrins.
Our results suggest that overexpression of the metastatic
biomarker ErbB2 (either alone or in cooperation with
14-3-3z) grants MECs a mechanical adaptability that is
not displayed by their non-cancerous counterparts (10A.vec)
or those overexpressing only 14-3-3z. MECs possessing the
ErbB2 transformation profile stiffen in response to increased
three-dimensional matrix stiffness (Fig. 2, B and D),
whereas the non-transformed control cells and 10A.14-3-
3z cells do not show a consistent or significant intracellular
stiffening response to increased three-dimensional matrix
stiffness (Fig. 2, A and C). In the mature, resting (non-preg-
nant and non-lactating) in vivo mammary gland, healthy
luminal MECs are nonmotile and line the ductal basement
membrane as a cell layer that is surrounded by an outer my-
oepithelial cell layer (42); however, MECs that overexpress
ErbB2 exhibit adaptive characteristics that drive epithelial
to mesenchymal transition (EMT) (43). Overexpression of
ErbB2 has been associated with cellular depolarization, as
well as hyperproliferation-induced luminal filling (8).
A dense lumen inherently transmits a relatively high stress
to individual MECs (37); nevertheless, MECs at this early
stage of breast cancer progression are still capable of
proliferating and may ultimately migrate through a dense
lumen to invade the basement membrane. Given their ability
to thrive and exert protrusive, migratory force in an envi-
ronment of elevated mechanical stress, it follows that the
associated sublines examined here (10A.ErbB2 and
10A.ErbB2.z) would be capable of wielding an internal
mechanical state that allows them to resist an increase in
ECM stress, a phenomenon that has been termed mechanor-
eciprocity (37).
Recent investigations have established ErbB2 overex-
pression as a significant effector of mechanotransduction
when MECs are exposed to a stiffened extracellular col-
lagen matrix. Mammary acini cultured in ribose-induced,
cross-linked-stiffened three-dimensional matrices have been
shown to exhibit stiffness-induced altered morphology;
yet, these organoids only developed invasive protrusions
into the stiffened matrices once their ErbB2 oncogenes
were activated (44). Moreover, ErbB2 activation did not
induce cellular invasiveness when the ECM stiffness was
not elevated. The same study determined that inhibition of
b1 integrin signaling prevented ErbB2-induced invasive
behavior within stiff matrices, which strongly suggests
that ErbB2 cooperates with integrin-sensed extracellular
mechanical cues to influence cancer progression (44).
This notion is consistent with the findings of this study,
which show that ErbB2 overexpression is associated withBiophysical Journal 99(7) 2048–2057increased intracellular stiffness sensitivity to collagen
matrix stiffness, for which the b1 integrin is the primary me-
chanosensor. Additionally, studies have established that
focal adhesion (FA) kinase (FAK), a key regulator of the
FA integrin clustering site, is critical to ErbB2-associated
oncogenic transformation (45,46) and that FAK promotes
transformation and invasion in response to elevated collagen
matrix stiffness (32). In conjunction with these prior studies,
our results further implicate a strong connection between b1
integrins and ErbB2 overexpression for cells within
mechanically perturbed extracellular environments.
The lack of intracellular mechanical adaptability observed
for non-cancerous MECs may in part explain their suscepti-
bility to a relatively high stress matrix environment. Several
studies performed on non-transformed MECs show that
prolonged exposure to elevated matrix stiffness induces
abnormal morphology and acinar organization (3,32,33),
hyperproliferation (8), and aberrant signaling and gene
expression (32,46–48), all of which drive eventual malignant
transformation. On the other hand, constitutively activated
mechanotransduction that characterizes transformed MECs
(37) is consistent with the intracellular stiffening that we
find of the fully transformed, invasive cells in this study.
While the 10A.14-3-3z cells did not exhibit an appreciable
intracellular mechanical response to changes in matrix stiff-
ness (Fig. 2 C), cells that overexpressed both 14-3-3z and
ErbB2 (10A.ErbB2.z) did show a significant response
(Fig. 2 D). Therefore, relevance of the 10A.14-3-3z cells
is twofold. First, the mechanical non-responsiveness of
10A.14-3-3z cells serves as a negative control for the
10A.ErbB2.z response, which further implicates ErbB2 as
a significant regulator of the cellular mechanical envi-
ronment with regard to cancer progression. Second, the
mechanical non-responsiveness of 10A.14-3-3z cells further
demonstrates the distinct contributions of 14-3-3z and ErbB2
to cancer progression. Previous studies show that ErbB2
promotes hyperproliferation (8), while 14-3-3z promotes
resistance to apoptosis and EMT via downregulation of p53
and E-cadherin (12,14). Additionally, this study now
suggests that overexpression of ErbB2 confers intracellular
mechanical sensitivity to matrix rigidity, while overexpres-
sion of 14-3-3z confers individual cells with morphological
irregularity that is associated with invasive phenotypes in
three-dimensional matrices (32,33).
Among the MECs that possess transforming potential, we
find that overexpression of ErbB2 alone is associated with
the greatest intracellular mechanical sensitivity to matrix
stiffness. As the matrix stiffness increases from 104 to
391 Pa, the percent increase in intracellular stiffness is high-
est for 10A.ErbB2 cells, followed by 10A.ErbB2.z cells, and
then by 10A.14-3-3z cells. Owing to prior studies that
examined migratory propensity of these MCF10A sublines
(14), our data suggests that transformation profile (overex-
pression of ErbB2 and/or 14-3-3z) may produce a similar
effect on both cell motility and intracellular stiffness
Transforming Potential and Matrix Stiffness Govern Cell Stiffness 2055sensitivity (Fig. 3). Trans-well migration and two-dimen-
sional wound healing assays showed that cell motility was
found to exhibit a comparable relationship with ErbB2
status: motility was highest for cells overexpressing ErbB2
alone, lowest for cells overexpressing 14-3-3z but not
ErbB2, and moderate for cells co-overexpressing both
biomarkers (14). This parallel of motility and stiffness sensi-
tivity is also consistent with recent investigations that reveal
ErbB2 regulation of FA turnover via the Src-FAK signaling
pathway (46). Given the connection among enhanced epi-
dermal growth factor receptor signaling and upregulated
b1 integrin activity (48), the role of b1 integrins in relaying
force between ECM collagen fibers and the cytoskeleton
(38), and the involvement of FAs in cell migration and
cell contractility (49), ErbB2 influence on intracellular stiff-
ness sensitivity suggests yet another link that relates cell
stiffness, cell motility, and matrix elasticity to one another.
Computational models predict that for a given cell type,
cell migration speed will gradually increase as three-dimen-
sional matrix stiffness increases and porosity decreases,
until the matrix stiffness reaches a critical value at which
migration speed decreases thereafter, due to relatively
high cell adhesivity and steric resistance presented by
matrix ligands (50,51). Future examination of this phenom-
enon for the cancer progression series examined in this
study may provide significant insights into the connections
among intracellular stiffness, matrix stiffness, and cell
motility, and even more importantly, how these relationships
are influenced by transforming potential with respect to
a purely three-dimensional extracellular environment.
Examining single cells within three-dimensional matrices
(integrin-mediated attachments) may provide insight into
the state of cells attached to other cells (cadherin-mediated
attachments) as well. Epithelial cells that form single cell
layers along inner surfaces of hollow structures possess
a free, unengaged surface; in contrast, cells that form attach-
ments around their entire surface, whether mediated by
integrins or cadherins, experience an inherently more con-
strained intracellular environment (21). However, given
that both b1 integrins and cadherins transmit tension
through the cytoskeletal network, we should expect to see
similar trends in intracellular stiffness as a function of
matrix stiffness when cells form cadherin-mediated cell-
cell attachments as well. The degree of measured intracel-
lular stiffness sensitivity expected for cells that form
cell-cell attachments would likely depend, in part, on the
extent to which the cells are attached to other cells versus
ECM. For example, a cell that is attached mostly to other
cells and only minimally to ECMwould likely show a muted
sensitivity to matrix stiffness because relatively little cell
surface area is available for matrix engagement. Alterna-
tively, a cell that is attached mostly to ECM and only mini-
mally to other cells may exhibit a higher intracellular
stiffness sensitivity to matrix stiffness, relative to a cell of
the former case.While we did not observe a matrix-stiffness-dependent
effect on single-cell morphology of the MCF10A sublines
examined here, analyzing the relationship between trans-
forming potential and intracellular stiffness of MECs in
three-dimensional matrices did yield an important para-
digm: this interplay is matrix-stiffness-dependent and can-
not be relegated to a universal association (Table 1). Our
PTMR data shows that within the softest matrix envi-
ronment, intracellular stiffness of partially transformed
10A.14-3-3z cells is less than that of non-transformed cells,
but that intracellular stiffness is recovered to some degree
for fully invasive cells (Fig. 4 A). Conversely, ErbB2 expres-
sion is the dominating factor that affects intracellular stiff-
ness within the stiffest of matrices (Fig. 4 C).
Matrix stiffness also affects the differential in intracel-
lular stiffness between non-cancerous and fully invasive
MECs, whereby non-cancerous cells are notably stiffer in
softer matrices, while this differential reverses in more rigid
matrices (Fig. 4 D). This result is interesting in light of the
fact that normal, resting mammary tissue is relatively com-
pliant, with a shear modulus that is ~1  102 Pa (44). The
stiffness of mammary ECM adjacent to tumors is elevated,
with a modulus that is approximately twice (2  102 Pa)
that of normal tissue, and the modulus of mammary tumor
masses increases even further to ~9  102 Pa (44). Our
studies probe the intracellular mechanical response as the
ECM progressively stiffens from a typical, resting mechan-
ical state (from 104 to 391 Pa). Our results indicate that
within a relatively normal, soft matrix environment, MECs
that possess transforming potential may not be capable
of fully manifesting the survival advantages (hyperprolifer-
ative and antiapoptotic mechanisms) that have been
associated with perturbed matrix stiffness-induced mecha-
notransduction, as evidenced by their relatively low level
of intracellular stiffness (Fig. 4 A). Yet, within relatively
stiffer matrices (Fig. 4, B and C), the intracellular stiffness
of these cells approaches and even exceeds that of non-
transformed cells for the case of 10A.ErbB2 cells within
the stiffest matrix. This again emphasizes the synergism
among elevated matrix stiffness, FAs, integrins, and
increased motility in driving breast cancer progression, as
all of these elements affect the cytoskeletal organization
that underlies intracellular stiffness (52).
In summary, our studies provide novel insights into the
subject matter of breast cancer mechanobiology by demon-
strating that transforming potential couples with matrix
stiffness to dictate the intracellular mechanical state of
MECs. The interactions between ErbB2 and 14-3-3z are
complex, and further clarification of these connections
may arise from additional future studies that examine their
individual and cooperative roles in three-dimensional
motility and in EMT-related signal transduction. Several
significant earlier investigations have shaped the present
understanding by examining MEC aggregate morphology
within three-dimensional matrices (33), global mammaryBiophysical Journal 99(7) 2048–2057
2056 Baker et al.tissue stiffness (3), two-dimensional MEC traction forces
(3), two-dimensional indentation analyses of MECs (53),
MEC FA activity (46), and MEC b1 integrin signaling (54).
Via PTMR, we have added to this knowledge base by
directly probing the intracellular space of MECs embedded
within three-dimensional matrices, which have been shown
to recapitulate fundamental properties of MECs that do not
manifest in two-dimensional cultures (23,48,55). An
improved understanding of internal MEC rheology holds
wide-reaching potential that may eventually influence the
design of targeted drug transport as well as evolve the
systems biology framework of cancer. With continued
investigations that focus on simulating in vivo environments
of MECs, the field of breast cancer biology will continue to
advance and ultimately reduce the impact of breast cancer
on human mortality.
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